[ET Net News Agency, 17 April 2024] IMMUNEONCO-B (01541) rose 10% to HK$15.62, breaking
above the 20-D SMA of HK$15.226.
It hits an intra-day high of HK$15.8, and an intra-day low of HK$14.14. The total shares
traded was 78,200, with a value of HK$1.15m. The active buy/sell ratio is 74:26, with net
buying turnover of HK$545,148. CHINA INNOVATION MARKET SER accounts for greatest net
responsive buying turnover of HK$59,074, with volume weighted average price of HK$15.148.
CHINA INV INFO accounts for greatest net responsive selling turnover of HK$204,407, with
volume weighted average price of HK$14.696.
Basic Information
=================
----------------------------------
Nominal 15.620 % Chg +10.00%
High 15.800 Low 14.140
Shares Tr 78,200 Turnover 1.15m
10-D SMA 14.736 %H.V 77.398
20-D SMA 15.226 VWAP 14.752
50-D SMA 18.030 RSI14 47.465
----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 74:26, with net buying
turnover of HK$545,148
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
IMMUNEONCO-B (01541) 15.62 +10.00
GENSCRIPT BIO (01548) 11.52 -1.03
INNOVENT BIO (01801) 34.40 -0.86
EVEREST MED-B (01952) 22.80 +0.22
LAEKNA-B (02105) 6.77 +3.83
SIRNAOMICS-B (02257) 7.35 +22.09
WUXI BIO (02269) 13.08 +0.31
BEIGENE (06160) 80.70 -1.71
SCICLONE PHARMA (06600) 18.02 +0.11
AKESO (09926) 46.80 -0.43
-----------------------------------------------
(ed)